It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MLAB’s FA Score shows that 0 FA rating(s) are green whileNOVT’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MLAB’s TA Score shows that 5 TA indicator(s) are bullish while NOVT’s TA Score has 2 bullish TA indicator(s).
MLAB (@Electronic Equipment/Instruments) experienced а -19.66% price change this week, while NOVT (@Electronic Equipment/Instruments) price change was -6.45% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -4.30%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was -5.33%.
MLAB is expected to report earnings on Feb 10, 2025.
NOVT is expected to report earnings on Feb 26, 2025.
This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
MLAB | NOVT | MLAB / NOVT | |
Capitalization | 592M | 6.27B | 9% |
EBITDA | 38.9M | 170M | 23% |
Gain YTD | 3.303 | 1.063 | 311% |
P/E Ratio | 660.35 | 85.22 | 775% |
Revenue | 213M | 882M | 24% |
Total Cash | 28.2M | 105M | 27% |
Total Debt | 236M | 405M | 58% |
MLAB | NOVT | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 28 | |
SMR RATING 1..100 | 97 | 71 | |
PRICE GROWTH RATING 1..100 | 59 | 50 | |
P/E GROWTH RATING 1..100 | 88 | 20 | |
SEASONALITY SCORE 1..100 | 75 | 19 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MLAB's Valuation (93) in the Medical Specialties industry is in the same range as NOVT (93) in the Electronic Equipment Or Instruments industry. This means that MLAB’s stock grew similarly to NOVT’s over the last 12 months.
NOVT's Profit vs Risk Rating (28) in the Electronic Equipment Or Instruments industry is significantly better than the same rating for MLAB (100) in the Medical Specialties industry. This means that NOVT’s stock grew significantly faster than MLAB’s over the last 12 months.
NOVT's SMR Rating (71) in the Electronic Equipment Or Instruments industry is in the same range as MLAB (97) in the Medical Specialties industry. This means that NOVT’s stock grew similarly to MLAB’s over the last 12 months.
NOVT's Price Growth Rating (50) in the Electronic Equipment Or Instruments industry is in the same range as MLAB (59) in the Medical Specialties industry. This means that NOVT’s stock grew similarly to MLAB’s over the last 12 months.
NOVT's P/E Growth Rating (20) in the Electronic Equipment Or Instruments industry is significantly better than the same rating for MLAB (88) in the Medical Specialties industry. This means that NOVT’s stock grew significantly faster than MLAB’s over the last 12 months.
MLAB | NOVT | |
---|---|---|
RSI ODDS (%) | 2 days ago71% | N/A |
Stochastic ODDS (%) | 2 days ago67% | 2 days ago51% |
Momentum ODDS (%) | 2 days ago67% | 2 days ago53% |
MACD ODDS (%) | 2 days ago77% | 2 days ago56% |
TrendWeek ODDS (%) | 2 days ago71% | 2 days ago57% |
TrendMonth ODDS (%) | 2 days ago75% | 2 days ago56% |
Advances ODDS (%) | 4 days ago65% | 11 days ago69% |
Declines ODDS (%) | 2 days ago76% | 2 days ago62% |
BollingerBands ODDS (%) | 2 days ago66% | 2 days ago75% |
Aroon ODDS (%) | 2 days ago57% | N/A |
A.I.dvisor indicates that over the last year, MLAB has been loosely correlated with NOVT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MLAB jumps, then NOVT could also see price increases.
Ticker / NAME | Correlation To MLAB | 1D Price Change % | ||
---|---|---|---|---|
MLAB | 100% | -4.11% | ||
NOVT - MLAB | 44% Loosely correlated | -2.58% | ||
ESE - MLAB | 43% Loosely correlated | -0.49% | ||
FARO - MLAB | 39% Loosely correlated | -3.11% | ||
TRMB - MLAB | 39% Loosely correlated | -0.23% | ||
KEYS - MLAB | 38% Loosely correlated | -2.43% | ||
More |
A.I.dvisor indicates that over the last year, NOVT has been loosely correlated with CGNX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NOVT jumps, then CGNX could also see price increases.
Ticker / NAME | Correlation To NOVT | 1D Price Change % | ||
---|---|---|---|---|
NOVT | 100% | -2.58% | ||
CGNX - NOVT | 64% Loosely correlated | -1.75% | ||
KEYS - NOVT | 63% Loosely correlated | -2.43% | ||
TRMB - NOVT | 62% Loosely correlated | -0.23% | ||
ESE - NOVT | 60% Loosely correlated | -0.49% | ||
MKSI - NOVT | 59% Loosely correlated | -0.86% | ||
More |